Apple again banned from selling watches in U.S. with blood oxygen sensor – By Kif Leswing & Rohan Goswami (CNBC) / Jan 17, 2024
- A federal appeals court will allow a ban on Apple Watch Series 9 sales to resume on Thursday.
- A patent dispute between Apple and technology company Masimo over blood oxygen senor technology has intermittently disrupted sales of Apple’s latest smart watch.
- The resumed ban does not resolve Apple’s appeal to overturn the International Trade Commission’s decision.
Apple will again be barred from selling watches with blood oxygen sensors beginning Thursday, the U.S. Court of Appeals for the Federal Circuit said.
The court order Wednesday did not rule on Apple’s effort to overturn a U.S. International Trade Commission ban on the company selling the affected watches in the United States. But it lifted an injunction that had blocked the ban from taking effect while that appeal is pending.
The ban stems from an intellectual property dispute with Masimo, a medical device company. In October, the International Trade Commission found that Apple’s blood oxygen sensors had infringed on Masimo’s intellectual property.
